An edition of Breakthrough business models (2009)

Breakthrough business models

drug development for rare and neglected diseases and individualized therapies : workshop summary

by

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Cover of: Breakthrough business models by Theresa M. Wizemann
Not in Library

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today
Notes
  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Notes

Check nearby libraries

Buy this book

Last edited by MARC Bot
November 30, 2023 | History
Edit
An edition of Breakthrough business models (2009)

Breakthrough business models

drug development for rare and neglected diseases and individualized therapies : workshop summary

by

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."--P. 3.

Publish Date
Publisher
National Academies Press
Language
English
Pages
131

Check nearby libraries

Buy this book

Previews available in: English

Subjects
Government policy, Drugs, Economics, Economic Models, Research, Trends, Design, Pharmaceutical policy, Orphan Drug Production, Orphan drugs, Drugs, design, Econometric models, Research, economic aspects
Places
United States

Showing 1 featured edition. View all 1 editions?

Edition Availability
Cover of: Breakthrough business models
Breakthrough business models: drug development for rare and neglected diseases and individualized therapies : workshop summary
2009, National Academies Press
in English
  • Not in Library
Libraries near you: WorldCat

Add another edition?

Book Details

Table of Contents

Introduction and overview
Current model for financing drug development : from concept through approval
The Food and Drug Administration's Orphan Drug Program
Diverse funding models
Strategies for facilitating sharing of research materials and data
Strategies of navigation intellectual property
Strategies for facilitating clinical trials
Summary.

Edition Notes

Include bibliographical references (p. 104-105).

Also available online.

Published in
Washington, D.C

Classifications

Dewey Decimal Class
615/.19
Library of Congress
RA401.A3 W59 2009, , RA401.A3 B74 2009

The Physical Object

Pagination
xviii, 131 p. :
Number of pages
131

ID Numbers

Open Library
OL24391044M
Internet Archive
breakthroughbusi00wize
ISBN 10
0309120888
ISBN 13
9780309120883
LCCN
2010478547
OCLC/WorldCat
317114592

Source records

Library of Congress MARC record
Internet Archive item record
Better World Books record
Library of Congress MARC record
marc_columbia MARC record
harvard_bibliographic_metadata record

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON / OPDS | Wikipedia citation
November 30, 2023 Edited by MARC Bot import existing book
December 26, 2022 Edited by MARC Bot import existing book
October 9, 2020 Edited by ImportBot import existing book
September 24, 2020 Edited by MARC Bot import existing book
October 23, 2010 Created by ImportBot Imported from Library of Congress MARC record